AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Jul 26, 2012
29864_dirs_2012-07-26_ab0838d7-4b4f-4c75-9fa3-1dd2966a6381.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-07-25
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-25 | Common Stock | M | 4000 | $15.60 | Acquired | 636895 | Direct |
| 2012-07-25 | Common Stock | S | 1300 | $48.69 | Disposed | 635595 | Direct |
| 2012-07-25 | Common Stock | S | 2700 | $49.16 | Disposed | 632895 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-25 | Employee Stock Option (right to buy) | $15.60 | M | 4000 | Disposed | 2013-01-17 | Common Stock (4000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 13286 | Indirect |
| Common Stock | 300000 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $48.69 (range $48.19 to $48.98).
F3: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $49.16 (range $49.00 to $49.34).
F5: Common stock held in grantor retained annuity trusts.
F6: Fully vested.